In conclusion, synthetic PACAP ameliorates intestinal and systemic inflammation following T. gondii induced acute ileitis in a duration-of-treatment dependent manner and hence provides an alternative option for prophylaxis and treatment of intestinal inflammation such as inflammatory bowel diseases. The gene discussed is ADCYAP1; the disease is inflammatory bowel disease.